Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Fiala

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
JCO Oncology Practice|June 17, 2024
Financial Toxicity and Willingness-to-Pay for Cancer Treatment Among People With Multiple MyelomaMark A Fiala
Pediatric Blood & Cancer|October 9, 2021
Disparities in health care affordability among childhood cancer survivors persist following the Affordable Care ActMark A Fiala
Translational Behavioral Medicine|July 13, 2022
Screening recommendation adherence among first-degree relatives of individuals with colorectal cancerMark A Fiala
Journal of General Internal Medicine|January 22, 2025
Disparities in Access and Utilization of Electronic Health Record Patient PortalsAtman Shah, Mark A Fiala
European Journal of Haematology|December 15, 2017
Falls in older adults with multiple myelomaTanya M Wildes, Mark A Fiala
Cancer|January 14, 2017
Racial disparities in treatment use for multiple myelomaMark A Fiala, Tanya M Wildes
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2020
Racial Disparities in the Utilization of Novel Agents for Frontline Treatment of Multiple MyelomaMark A Fiala, Tanya M Wildes, Ravi Vij
Clinical Lymphoma, Myeloma & Leukemia|July 20, 2019
A Mixed-Methods Study of Stem Cell Transplantation Utilization for Newly Diagnosed Multiple MyelomaMark A Fiala, Ravi Vij, Tanya M Wildes
JCO Clinical Cancer Informatics|December 15, 2018
Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple MyelomaHira S Mian, Tanya M Wildes, Mark A Fiala
Journal of Geriatric Oncology|March 22, 2021
Bortezomib in first-line therapy is associated with falls in older adults with multiple myelomaKelly L Schoenbeck, Mark A Fiala, Tanya M Wildes
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
JCO Oncology Practice|June 17, 2024
Financial Toxicity and Willingness-to-Pay for Cancer Treatment Among People With Multiple MyelomaMark A Fiala
Pediatric Blood & Cancer|October 9, 2021
Disparities in health care affordability among childhood cancer survivors persist following the Affordable Care ActMark A Fiala
Translational Behavioral Medicine|July 13, 2022
Screening recommendation adherence among first-degree relatives of individuals with colorectal cancerMark A Fiala
Journal of General Internal Medicine|January 22, 2025
Disparities in Access and Utilization of Electronic Health Record Patient PortalsAtman Shah, Mark A Fiala
European Journal of Haematology|December 15, 2017
Falls in older adults with multiple myelomaTanya M Wildes, Mark A Fiala
Cancer|January 14, 2017
Racial disparities in treatment use for multiple myelomaMark A Fiala, Tanya M Wildes
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2020
Racial Disparities in the Utilization of Novel Agents for Frontline Treatment of Multiple MyelomaMark A Fiala, Tanya M Wildes, Ravi Vij
Clinical Lymphoma, Myeloma & Leukemia|July 20, 2019
A Mixed-Methods Study of Stem Cell Transplantation Utilization for Newly Diagnosed Multiple MyelomaMark A Fiala, Ravi Vij, Tanya M Wildes
JCO Clinical Cancer Informatics|December 15, 2018
Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple MyelomaHira S Mian, Tanya M Wildes, Mark A Fiala
Journal of Geriatric Oncology|March 22, 2021
Bortezomib in first-line therapy is associated with falls in older adults with multiple myelomaKelly L Schoenbeck, Mark A Fiala, Tanya M Wildes
Pageof 8